Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib

MIDORI MORITA, ASAKO OOE, WATARU ISHII, AKIRA WATANABE, CHISE MATSUI, YUKA OKUYAMA, SAE KITANO, CHIKAGE KATO, MIE ONISHI, KOICHI SAKAGUCHI and YASUTO NAOI
Anticancer Research June 2023, 43 (6) 2783-2789; DOI: https://doi.org/10.21873/anticanres.16447
MIDORI MORITA
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: midori{at}koto.kpu-m.ac.jp
ASAKO OOE
2Breast Surgery Unit, Kyoto Okamoto Memorial Hospital, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WATARU ISHII
3Breast Surgery Unit, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIRA WATANABE
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHISE MATSUI
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKA OKUYAMA
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAE KITANO
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIKAGE KATO
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIE ONISHI
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOICHI SAKAGUCHI
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUTO NAOI
1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 6 2783-2789
DOI 
https://doi.org/10.21873/anticanres.16447
PMID 
37247903

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 3, 2023
  • Revision received March 23, 2023
  • Accepted March 30, 2023
  • Published online May 29, 2023.

Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. MIDORI MORITA1⇑,
  2. ASAKO OOE2,
  3. WATARU ISHII3,
  4. AKIRA WATANABE1,
  5. CHISE MATSUI1,
  6. YUKA OKUYAMA1,
  7. SAE KITANO1,
  8. CHIKAGE KATO1,
  9. MIE ONISHI1,
  10. KOICHI SAKAGUCHI1 and
  11. YASUTO NAOI1
  1. 1Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan;
  2. 2Breast Surgery Unit, Kyoto Okamoto Memorial Hospital, Kyoto, Japan;
  3. 3Breast Surgery Unit, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan
  1. Correspondence to: Midori Morita, MD, Ph.D., Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. Tel: +81 752515111 (5534), Fax: +81 752510270, e-mail: midori{at}koto.kpu-m.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 43 (6)
Anticancer Research
Vol. 43, Issue 6
June 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
MIDORI MORITA, ASAKO OOE, WATARU ISHII, AKIRA WATANABE, CHISE MATSUI, YUKA OKUYAMA, SAE KITANO, CHIKAGE KATO, MIE ONISHI, KOICHI SAKAGUCHI, YASUTO NAOI
Anticancer Research Jun 2023, 43 (6) 2783-2789; DOI: 10.21873/anticanres.16447

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
MIDORI MORITA, ASAKO OOE, WATARU ISHII, AKIRA WATANABE, CHISE MATSUI, YUKA OKUYAMA, SAE KITANO, CHIKAGE KATO, MIE ONISHI, KOICHI SAKAGUCHI, YASUTO NAOI
Anticancer Research Jun 2023, 43 (6) 2783-2789; DOI: 10.21873/anticanres.16447
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Mechanism of CDK4/6 Inhibitor Resistance in Hormone Receptor-positive Breast Cancer and Alternative Treatment Strategies
  • Google Scholar

More in this TOC Section

  • Comparison of RATS Lobectomy and VATS Lobectomy for Early-stage Non-small Cell Lung Cancer
  • Effectiveness of Chemotherapy With/Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Population-based Target Trial Emulation Study
  • Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal Cancer
Show more Clinical Studies

Keywords

  • palbociclib
  • Breast cancer
  • Japanese
  • older patients
  • dose reduction
  • drug holiday
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire